Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 12, 2008

View Archived Issues

Effects of mycobacterial cell wall-DNA complex in bladder cancer not dependent on age

Hana completes phase I menadione trial in skin toxicity due to EGFR inhibitors

Viralytics to test Cavatak in head and neck cancer

Phosphagenics presents phase I clinical results for transdermal lidocaine

InSite Vision reports preliminary results from phase IIIa clinical trial of AzaSite Plus

AcelRx reports results from phase II clinical study of sufentanil in postoperative pain

BioWa licenses Potelligent to GSK for antibody development and commercialization

Portola commences phase II novel P2Y12 ADP receptor antagonist trial

Daiichi Sankyo initiates phase III DU-176b trial in patients with atrial fibrillation

Rib-X reports top-line results from phase II delafloxacin study

First-in-human study shows safety and biological effects of CSL-360 in acute myeloid leukemia

Pivotal studies to follow phase IIb trial of AP-12009 in glioma

Omeros presents results from phase I OMS-201 study

Preliminary phase II data suggest APD-125 did not meet trial endpoints

Recent Amgen patents describe novel treatments for anemia

Ferring and the Conaris Research Institute sign worldwide license agreement for FE-301

New antiglaucoma agents disclosed in recent Unimed patent

Recent ProMetic patent divulges novel agents for treatment of autoimmune diseases

Proteo and Minapharm receive approval in Cairo for Elafin phase II trial in kidney transplantation

Olanzapine long-acting injection approved in Europe for schizophrenia

Meda receives U.K. approval for ketoprofen/omeprazole combination

Perampanel well tolerated in phase II study in patients with refractory partial seizures

Abstral receives marketing approval in Germany for breakthrough cancer pain

Daiichi Sankyo submits application for approval of CS-866AZ in Japan

New data on JAK2 inhibitors from Exelixis presented at ASH meeting

Antileukemic effects of DCC-2036, DCC-2157 assessed in vivo

RAP-011 prevents skeletal metastases in a mouse model of metastatic breast cancer

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...